Cost-effectiveness of ribavirin interferon alfa-2B after interferon relapse in chronic hepatitis C.

被引：0
|
作者：
Wong, JB
Davis, GL
Pauker, SG
机构：
[1] Tufts New England Med Ctr, Div Clin Decis Making, Boston, MA USA
[2] Univ Florida, Dept Med, Sect Hepatobiliary Dis, Gainesville, FL USA
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1713
引用
收藏
页码：591A / 591A
页数：1
相关论文
共 50 条
  • [41] Cost-effectiveness of peginterferon alfa-2b in combination with ribavirin as initial treatment for chronic hepatitis C in Sweden
    Bernfort, Lars
    Sennfalt, Karin
    Reichard, Olle
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2006, 38 (6-7) : 497 - 505
  • [42] The role of genotyping in cost-effectiveness of interferon and ribavirin for chronic hepatitis C
    Younossi, ZM
    Singer, ME
    Shermock, KM
    McHutchison, JG
    GASTROENTEROLOGY, 1999, 116 (04) : A1293 - A1293
  • [43] Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
    Manns, MP
    McHutchison, JG
    Gordon, SC
    Rustgi, VK
    Shiffman, M
    Reindollar, R
    Goodman, ZD
    Koury, K
    Ling, MH
    Albrecht, JK
    LANCET, 2001, 358 (9286): : 958 - 965
  • [44] r-interferon alfa-2b/ribavirin combined therapy followed by low-dose r-interferon alfa-2b in chronic hepatitis C interferon nonresponders
    Perasso, A
    Testino, G
    Ansaldi, F
    Venturino, V
    Icardi, GC
    HEPATOLOGY, 1999, 29 (01) : 297 - 298
  • [45] Peginterferon alfa-2b plus ribavirin versus interferon alfa-2b plus ribavirin for chronic hepatitis C in HIV-coinfected patients
    Crespo, M
    Sauleda, S
    Esteban, JI
    Juarez, A
    Buti, M
    Pahissa, A
    Esteban, R
    Guardia, J
    HEPATOLOGY, 2005, 42 (04) : 701A - 702A
  • [46] A comparison of cost-effectiveness of peginterferon alfa-2a (40 KD) (pegasys) plus ribavirin (copegus) versus interferon alfa-2b Plus ribavirin as first treatment of chronic hepatitis C in the UK
    Lewis, GJ
    Green, J
    Patel, K
    Philips, Z
    VALUE IN HEALTH, 2004, 7 (06) : 763 - 764
  • [47] A dose-ranging study of pegylated interferon alfa-2b and ribavirin in chronic hepatitis C
    Glue, P
    Rouzier-Panis, R
    Raffanel, C
    Sabo, R
    Gupta, SK
    Salfi, M
    Jacobs, S
    Clement, RP
    HEPATOLOGY, 2000, 32 (03) : 647 - 653
  • [48] Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C
    Poynard, T
    McHutchison, J
    Manns, M
    Trepo, C
    Lindsay, K
    Goodman, Z
    Ling, MH
    Albrecht, J
    GASTROENTEROLOGY, 2002, 122 (05) : 1303 - 1313
  • [49] Interferon alfa-2b therapy for chronic hepatitis
    Kirchner, JT
    AMERICAN FAMILY PHYSICIAN, 1997, 55 (07) : 2434 - 2434
  • [50] Interferon alfa-2b and ribavirin for patients with chronic hepatitis C and normal ALT: Final results
    Jacobson, IM
    Russo, MW
    Lebovics, E
    Esposito, S
    Tobias, H
    Klion, F
    Brown, RS
    Dieterich, D
    Brass, C
    GASTROENTEROLOGY, 2002, 122 (04) : A627 - A627
12345